![](/img/cover-not-exists.png)
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
Jianghao Chen, Qing Yao, Dong Li, Juliang Zhang, Ting Wang, Ming Yu…Volume:
13
Language:
english
DOI:
10.1186/1471-2407-13-248
Date:
December, 2013
File:
PDF, 175 KB
english, 2013